Troluce Capital Advisors »

Janux Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $872k 32k 27.00
2024-12-31 $1.7M 32k 53.54

More positions owned by Troluce Capital Advisors

Fluor Corporation Call Option (FLR)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Kenvue (KVUE)
Honeywell International Call Option (HON)
Echostar Corp Cl A (SATS)
Capital One Financial (COF)
Dupont De Nemours (DD)
Oklo Com Cl A Put Option (OKLO)
Golar Lng SHS Call Option (GLNG)
EXACT Sciences Corporation Call Option (EXAS)
Amcor Ord (AMCR)
Standardaero (SARO)
Intel Corporation Call Option (INTC)
Equinix (EQIX)
U Haul Holding Company Com Ser N (UHAL.B)

View all positions for Troluce Capital Advisors

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics